Not for therapeutic, diagnostic, or cosmetic purposes
It involves weighing the costs, the benefits, and the sheer frustration factor of each approach
Hulst AH, Polderman JAW, Siegelaar SE, van Raalte DH, DeVries JH, Preckel B et al (2021) Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus
It depends on your health status and dosage
Evidence remains mixed and often limited to small trials or animal models
If the gastrointestinal effects of semaglutide are a dealbreaker, sermorelin offers a dramatically gentler experience